MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Freezing of gait in Parkinson’s disease: a review of current neuroimaging evidence for the development of effective therapies

A. Potvin-Desrochers, C. Paquette (Montreal, QC, Canada)

Meeting: 2019 International Congress

Abstract Number: 1957

Keywords: Gait disorders: Pathophysiology, Gait disorders: Treatment

Session Information

Date: Wednesday, September 25, 2019

Session Title: Neuroimaging

Session Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Objective: The objective of this review is to summarize the results of brain imaging studies assessing freezing of gait (FOG) and to provide new ideas for the management of FOG.

Background: FOG is a common motor symptom in Parkinson’s disease (PD) affecting up to 80% of adults in advanced PD [1]. In the last decades, studies have used several different brain imaging techniques and paradigms to explore the pathophysiology of FOG. Although the literature generally agrees that FOG is related to decreased activity in brainstem structures that organize gait due to an increased inhibitory drive from the basal ganglia [2], possible mechanisms leading to FOG have not been confirmed. Because FOG remains a mysterious motor symptom, there are few pharmacological, surgical and behavioural treatments options. In terms of rehabilitative interventions, there are currently no standardized approach for FOG. Thus, there is a clear need to better understand FOG pathophysiology in order to develop therapies specifically targeting FOG.

Method: The review was performed using Pubmed. To review neuroimaging literature in FOG, search terms included, among others,‘‘brain imaging’’, ‘‘magnetic resonance imaging’’, ‘‘positron emission tomography’’ and ‘‘freezing of gait’’.

Results: FOG seems to be associated with atrophy and altered activity in specific cognitive, limbic and sensorimotor areas thought to be involved in the different loops of the cortico-basal ganglia circuity. Brain connectivity also seems to be altered in FOG, especially within the visual, the frontoparietal and the sensorimotor networks.

Conclusion: FOG seems to be related to dysfunctional processing in the cortico-basal ganglia circuity. By knowing the proper neural mechanisms of FOG, non-invasive brain stimulation interventions, such as rTMS, could modify cortical excitability of appropriate brain areas. Combined with a gait and stability training, such rTMS interventions may have the potential to improve FOG.

References: [1] Tan, D. M., McGinley, J. L., Danoudis, M. E., Iansek, R., & Morris, M. E. (2011). Freezing of gait and activity limitations in people with Parkinson’s disease. Arch Phys Med Rehabil, 92(7), 1159–1165. doi:10.1016/j.apmr.2011.02.003 [2] Lewis, S. J., & Shine, J. M. (2016). The Next Step: A Common Neural Mechanism for Freezing of Gait. The Neuroscientist, 22(1), 72–82.

To cite this abstract in AMA style:

A. Potvin-Desrochers, C. Paquette. Freezing of gait in Parkinson’s disease: a review of current neuroimaging evidence for the development of effective therapies [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/freezing-of-gait-in-parkinsons-disease-a-review-of-current-neuroimaging-evidence-for-the-development-of-effective-therapies/. Accessed October 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/freezing-of-gait-in-parkinsons-disease-a-review-of-current-neuroimaging-evidence-for-the-development-of-effective-therapies/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley